Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CCCC
#3431
C4 Therapeutics, Inc.
2.8
5
USD
+2.52%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.52%
Monthly Change
+2.89%
6 month change
+34.43%
Year Change
+137.50%
Previous Close
2.7
8
Open
2.7
8
Bid
Ask
Low
2.7
6
High
2.8
6
Volume
105
Markets
US Stock Market
Healthcare
CCCC
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
43.12 M
48.74 M
49.05 M
68.6 M
70.99 M
97.58 M
—
Valuation ratios
Enterprise value
1.26 B
1.5 B
294.67 M
320.69 M
200.06 M
111.77 M
354.05 M
Price to earnings ratio
—
—
-2.44
-2.44
-2.37
-1.5
-4.81
Price to sales ratio
—
—
10.03
16.38
7.02
4.4
15.38
Price to cash flow ratio
—
—
-2.94
-3.03
-3.83
-1.6
-5.82
Price to book ratio
—
—
1.08
1.32
1.16
0.62
1.07
Enterprise value to EBITDA ratio
—
—
-2.91
-2.76
-1.62
-0.96
-2.9
Profitability ratios
Return on assets %
-0.17
-0.17
-0.3
-0.35
-0.3
-0.29
-0.35
Return on equity %
-0.24
-0.22
-0.44
-0.54
-0.49
-0.41
-0.57
Return on invested capital %
-460.27
-166.92
-258.91
-353.17
-358.18
-365.14
-419.29
Gross margin %
—
—
100
105.06
100
100
400
Operating margin %
—
—
-416.56
-703.74
-336.15
-320.53
-1 360.45
EBITDA margin %
—
—
-406.58
-717.92
-347.17
-323.87
-1 344.95
Net margin %
—
—
-412.19
-670.65
-295.96
-292.08
-1 238.66
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.69
6.36
6.46
6.34
5.71
7.81
24.32
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
0.07
0.05
0.1
0.1
0.12
Solvency ratios
Debt to assets ratio
0.03
0.02
0.03
0
—
—
—
Debt to equity ratio
0.04
0.03
0.04
0
—
—
—
Long term debt to total assets ratio
0.03
0.02
0.02
0
—
—
—
Long term debt to total equity ratio
0.04
0.03
0.03
0
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2.17
-2.15
-0.94
-1.19
-1.34
EBIT per share
—
—
-2.65
-2.82
-1.72
-1.39
-1.57
EBITDA per share
—
—
-2.59
-2.86
-1.78
-1.4
-1.55
Total debt per share
—
—
0.23
0
—
—
—
Cash per share
—
—
6.9
5.67
3.85
3.58
12.79
Net current asset value per share
—
—
5.89
5.46
3.72
3.11
12.41
Tangible book value per share
—
—
5.92
4.96
3.11
3.1
10.43
Working capital per share
—
—
4.97
4.6
3.06
2.72
10.32
Book value per share
—
—
5.92
4.96
3.11
3.1
10.43
News
What's Going On With C4 Therapeutics Stock Thursday? - C4 Therapeutics (NASDAQ:CCCC)
Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year?
Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice
Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year?
Barclays raises C4 Therapeutics stock price target on trial progress
TD Cowen reiterates Buy rating on C4 Therapeutics stock
C4 earnings beat by $0.11, revenue topped estimates
Brookline Capital raises C4 Therapeutics stock price target on trial progress
C4 Therapeutics doses first patient in phase 2 myeloma trial
C4 Therapeutics’ chief medical officer Reyno sells $22,200 in stock
C4 Therapeutics to advance cemsidomide trials for multiple myeloma
C4 Therapeutics stock initiated with Buy rating at TD Cowen